Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
United Kingdom (3)
Care Delivery/ Care pathway
Neurology/Parkinson's Disease (1)
NGO (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Shared purpose
Clinical study phase II